多中心分析:经颈静脉肝内门体分流术用于管理骨髓增殖性肿瘤相关门静脉高压
该多中心回顾性分析纳入1997至2016年间在三家学术医疗中心接受经颈静脉肝内门体分流术(TIPS)的29例骨髓增殖性肿瘤(MPN)相关门静脉高压患者,多数患者门静脉高压及其临床后遗症完全缓解,TIPS术后1、2、3、4年总生存率分别为96.4%、92.3%、84.6%、71.4%,但尽管接受治疗性抗凝,31.0%患者发生支架内血栓形成,需额外干预。
要点
- TIPS术后多数MPN相关门静脉高压患者获得完全临床缓解。
- TIPS术后1、2、3、4年总生存率分别为96.4%、92.3%、84.6%、71.4%。
- 尽管治疗性抗凝,31.0%患者发生支架内血栓形成,需额外干预。
核心结论
- TIPS可作为MPN相关门静脉高压的有效干预措施,无论病因如何。
- TIPS血栓形成是MPN人群中的常见并发症,应考虑TIPS术后无限期抗凝。
研究设计与样本
- 回顾性分析1997年至2016年间在三家学术医疗中心接受TIPS的29例MPN相关门静脉高压患者。
主要发现
- 多数患者TIPS术后门静脉高压及其临床后遗症完全临床缓解。
- TIPS术后1、2、3、4年总生存率分别为96.4%、92.3%、84.6%、71.4%。
- 尽管接受治疗性抗凝,31.0%患者在TIPS术后发生支架内血栓形成,需额外干预。
临床怎么用
- 作者认为TIPS可作为MPN相关门静脉高压的有效干预措施,无论病因如何。
- 作者提出应考虑TIPS术后无限期抗凝。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BCR-ABL1-negative myeloproliferative neoplasms (MPNs) are clonal stem cell disorders defined by proliferation of one or more myeloid lineages, and carry an increased risk of vascular events and progression to myelofibrosis and leukemia. Portal hypertension (pHTN) occurs in 7-18% of MPN patients via both thrombotic and nonthrombotic mechanisms and portends a poor prognosis. Transjugular intrahepatic portosystemic shunt (TIPS) has been used in the management of MPN-associated pHTN; however, data on long-term outcomes of TIPS in this setting is limited and the optimal management of medically refractory MPN-associated pHTN is not known. In order to assess the efficacy and long-term outcomes of TIPS in MPN-associated pHTN, we performed a retrospective analysis of 29 MPN patients who underwent TIPS at three academic medical centers between 1997 and 2016. The majority of patients experienced complete clinical resolution of pHTN and its clinical sequelae following TIPS. One, two, three, and four-year overall survival post-TIPS was 96.4%, 92.3%, 84.6%, and 71.4%, respectively. However, despite therapeutic anticoagulation, in-stent thrombosis occurred in 31.0% of patients after TIPS, necessitating additional interventions. In conclusion, TIPS can be an effective intervention for MPN-associated pHTN regardless of etiology. However, TIPS thrombosis is a frequent complication in the MPN population and indefinite anticoagulation post-TIPS should be considered.
引用
- Reilly CR, Babushok DV, Martin K, et al. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol. 2017. PMID: 28543980. doi:10.1002/ajh.24798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。